The Chemours financials
$13.89−1.70%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.59B | $1.38B | $1.33B | $1.50B | $1.61B | $1.37B | $1.36B | $1.51B | $1.55B | $1.36B | $1.41B | $1.49B |
| Gross profit | $286.0M | $212.0M | $156.0M | $233.0M | $278.0M | $236.0M | $265.0M | $286.0M | $308.0M | $284.0M | $255.0M | $273.0M |
| Gross margin | 18.0% | 15.4% | 11.7% | 15.6% | 17.2% | 17.3% | 19.5% | 19.0% | 19.8% | 20.9% | 18.1% | 18.4% |
| Operating income | -$213.0M | $26.0M | -$5.0M | $94.0M | -$192.0M | $53.0M | $61.0M | $19.0M | $125.0M | $115.0M | -$6.0M | -$46.0M |
| Net income | -$274.0M | -$29.0M | -$61.0M | $60.0M | -$380.0M | -$5.0M | -$12.0M | -$32.0M | $60.0M | $54.0M | -$18.0M | $12.0M |
| Net margin | −17.2% | −2.1% | −4.6% | 4.0% | −23.5% | −0.4% | −0.9% | −2.1% | 3.9% | 4.0% | −1.3% | 0.8% |
| Diluted EPS | $-1.81 | $-0.19 | $-0.41 | $0.40 | $-2.53 | $-0.03 | $-0.08 | $-0.22 | $0.39 | $0.36 | $-0.12 | $0.08 |
| EBITDA | -$130.0M | $118.0M | $80.0M | $177.0M | -$82.0M | $174.0M | $143.0M | $193.0M | $202.0M | $190.0M | $6.0M | $156.0M |
| Operating cash flow | $158.0M | -$44.0M | $137.0M | $146.0M | $93.0M | -$112.0M | $138.0M | $139.0M | -$620.0M | -$290.0M | $482.0M | $131.0M |
| Free cash flow | $114.0M | -$93.0M | $92.0M | $105.0M | $50.0M | -$196.0M | $29.0M | $63.0M | -$693.0M | -$392.0M | $347.0M | $45.0M |
| Diluted shares | 151.2M | 150.8M | 150.0M | 150.8M | 150.2M | 149.9M | 150.8M | 149.7M | 150.1M | 150.1M | 145.2M | 150.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $671.0M | $563.0M | $670.0M | $613.0M | $502.0M | $464.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $3.87B | $4.14B | $4.14B | $4.15B | $4.14B | $4.11B |
| Total assets | $7.15B | $7.27B | $7.38B | $7.57B | $7.49B | $7.39B |
| Total liabilities | $7.20B | $7.05B | $7.13B | $7.27B | $7.25B | $6.81B |
| Shareholders' equity | -$48.0M | $216.0M | $251.0M | $300.0M | $239.0M | $580.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology